Successful Management of Acquired Hemophilia A Associated with Bullous Pemphigoid: A Case Report and Review of the Literature

Lung, Respiratory and Thoracic CancerLymphoma

Patient harboring a novel PIK3CA point mutation after acquired resistance to crizotinib in an adenocarcinoma with ROS1 rearrangement: A case report and literature review

Thorac Cancer.

Xu CW, Wang WX, Huang RF, He C, Liao XH, Zhu YC, Du KQ, Zhuang W, Chen YP, Chen G, Fang MY

doi: 10.1111/1759-7714.12496.

Hemophilia in Sports: A Case Report and Prophylactic Protocol

J Athl Train.

Maffet M, Roton J Jr

doi: 10.4085/1062-6050-51.11.14.

Skin Cancer

mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibition

Oncotarget.

Xue G, Kohler R, Tang F, Hynx D, Wang Y, Orso F, Prêtre V, Ritschard R, Hirschmann P, Cron P, Roloff T, Dummer R, Mandalà M, Bichet S, Genoud C, Meyer AG, Muraro MG, Spagnoli GC, Taverna D, Rüegg C, Merghoub T, Massi D, Tang H, Levesque MP, Dirnhofer S, Zippelius A, Hemmings BA, Wicki A

doi: 10.18632/oncotarget.18213.

Radio-Oncology

Esophageal pulmonary fistula - a rare complication of radiation therapy: a case report

J Med Case Rep.

Buemi L, Stefanelli S, Bichard P, Luscher M, Becker M.

doi: 10.1186/s13256-018-1658-3.

Non-Malignant Blood Disorders

Maintenance rituximab for relapsing thrombotic thrombocytopenic purpura: a case report

Transfusion.

Saleem R, Rogers ZR, Neunert C, George JN

doi: 10.1111/trf.15093.

Lung, Respiratory and Thoracic CancerFurther Publications

Response to Osimertinib in a Patient With Non-Small Cell Lung Cancer and Two Uncommon EGFR mutations

healthbook TIMES Oncology Hematology

Astaras C, Bettini A, Betticher D.C

doi: 10.36000/hbT.OH.2020.03.01

Lung, Respiratory and Thoracic CancerLymphoma

Concomitant Presence of EGFR and ALK Fusion Gene Mutation in Adenocarcinoma of Lung: A Case Report and Review of the Literature

J Pharm Pract.

Thumallapally N, Yu H, Farhan M, Ibrahim U, Odiami M

doi: 10.1177/

Skin Cancer

Genomic profiling of a dedifferentiated mucosal melanoma following exposure to immunotherapy

Melanoma Res.

Prior L, Toomey S, Greally M, Keane F, Lim M, Harrold E, O'Keane C, Bulger K, Hennessy BT, Furney SJ, McCaffrey J

doi: 10.1097/CMR.0000000000000636.

Lung, Respiratory and Thoracic CancerLymphoma

Identification of a novel T1151K ALK mutation in a patient with ALK-rearranged NSCLC with prior exposure to crizotinib and ceritinib

Lung Cancer.

Zhu VW, Cui JJ, Fernandez-Rocha M, Schrock AB, Ali SM, Ou SI

doi: 10.1016/

Related content

Patient harboring a novel PIK3CA point mutation after acquired resistance to crizotinib in an adenocarcinoma with ROS1 rearrangement: A case report and literature review

Hemophilia in Sports: A Case Report and Prophylactic Protocol

mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibition

Esophageal pulmonary fistula - a rare complication of radiation therapy: a case report

Maintenance rituximab for relapsing thrombotic thrombocytopenic purpura: a case report

Response to Osimertinib in a Patient With Non-Small Cell Lung Cancer and Two Uncommon EGFR mutations

Concomitant Presence of EGFR and ALK Fusion Gene Mutation in Adenocarcinoma of Lung: A Case Report and Review of the Literature

Genomic profiling of a dedifferentiated mucosal melanoma following exposure to immunotherapy

Identification of a novel T1151K ALK mutation in a patient with ALK-rearranged NSCLC with prior exposure to crizotinib and ceritinib